Blog
Will I Go to Jail If the DEA Investigates My Practice?
Most practitioners who receive a visit from the DEA will not see the inside of a federal courtroom, let alone a federal prison. That sentence will not comfort you if agents arrived at your office this morning. It is, if we are being precise, not meant to comfort. It is meant to calibrate. At Spodek Law Group, we’ve seen it all – and our goal is to help you answer the question: does being investigated, automatically result in jail time?
The question everyone asks first is the wrong question. “Will I go to jail” presupposes a single track. The DEA operates on two tracks at the same time. One track is administrative: a Letter of Admonition, a corrective action plan, possible revocation of your registration. The other is criminal: referral to the Department of Justice, a grand jury, an indictment, and the kind of sentencing that measures itself in decades. The gap between these two tracks is not a matter of luck. It is a matter of evidence, timing, and whether anyone told you what was happening while the decision was still being made.
What the Government Must Prove After Ruan
In June 2022, the Supreme Court held in Ruan v. United States, without a single dissent, that prosecutors must demonstrate a physician knew prescriptions lacked a legitimate medical purpose before being convicted and sent to jail. Not that the prescriptions were unusual. Not that another physician would have prescribed otherwise. That the physician acted with conscious disregard for the boundaries of authorized practice.
Before Ruan, the standard was objective and straightforward. A prosecutor could present expert testimony that no reasonable physician would have prescribed as the defendant did, and that was sufficient for conviction. Physicians went to prison under a legal framework that all nine justices later declared incorrect. Dr. Xiulu Ruan received over twenty years. Dr. Shakeel Kahn faced similar consequences. The standard that put them there did not survive review.
One does not answer the question “will I go to jail” without first answering the question the government must answer at trial: did you know?
The shift from objective to subjective is not academic. It reshapes the architecture of every federal controlled substances prosecution in the country. The government can no longer point to your prescribing volume and call it a crime. It must demonstrate that you understood your conduct fell outside the course of professional practice and continued regardless. Good faith, under Ruan, is not a defense strategy. It is a constitutional barrier the prosecution must clear.
There are exceptions, though in practice they tend to confirm the rule.
The Two Tracks
A DEA investigation begins, in most instances, the way ordinary things begin: with a number in a database. The Automation of Reports and Consolidated Orders System compares your prescribing patterns against practitioners of similar specialty in your region. If the number is high enough, a diversion investigator opens a file. From that file, one of two paths emerges.
The administrative path produces an audit, a Form 82, a request for informed consent. If violations surface, they are documented in a report. The DEA may issue a Letter of Admonition. It may seek revocation of your registration. These are severe consequences for a practitioner whose livelihood depends on the authority to prescribe. They are not, however, incarceration.
The criminal path produces something else entirely. A referral to the Department of Justice. Undercover agents posing as patients in your waiting room. A grand jury convened without your knowledge. A sealed indictment. A search warrant executed at your office, your vehicle, your home. Bank accounts frozen. Patient records seized. The practice destroyed before any verdict is rendered, because the raid itself is the verdict the community registers.
In the 2025 National Health Care Fraud Takedown, the Department of Justice charged 324 defendants across fifty federal districts, including 44 licensed medical professionals accused of diverting over fifteen million pills of prescription opioids. The DEA initiated more than ninety administrative actions in the six months preceding that announcement. Those numbers reveal the ratio that matters: for every criminal prosecution, there are administrative resolutions that never make the news. The administrative track is quieter. It is also, for most practitioners, more probable.
The Window You Do Not Know Exists
Between the opening of an investigation and the referral decision, there is a period of approximately four to six months during which the DEA is reviewing your charts, interviewing your staff, and constructing a narrative about your practice. This is the period when the trajectory is determined. It is also the period during which most practitioners have no idea they are being investigated.
And that is the structural problem. The decision that governs whether you face administrative sanctions or federal prosecution is made during a window you cannot see, regarding evidence you have not been asked to explain, by investigators who are not required to inform you of their conclusions until after those conclusions have been reached.
I have spoken with practitioners who learned of a two year investigation on the morning agents appeared at their doors. The investigation had a beginning, a middle, and a resolution. The practitioner was present for none of it.
What Triggers the Criminal Track
The DEA does not prosecute prescribing volume alone. If it did, every high volume pain management specialist in the country would face indictment. What triggers the criminal track is the accumulation of indicators that, taken together, permit the government to characterize legitimate medical practice as distribution.
Cash payments constitute one such indicator. Patients traveling long distances constitute another. Prescriptions written without adequate examination, without documentation supporting the diagnosis, without evidence that alternatives were considered, without any indication that the physician paused long enough to ask why a patient who lives four hours away chose this particular office for this particular prescription: each of these, alone, is an administrative deficiency. Together, they compose a portrait. The portrait is not of a careless physician. It is of a physician the government will argue understood what was happening and chose not to intervene.
The government constructs its case the way a condemned building accumulates violations: no single crack in the foundation is fatal, but the inspector is not looking at any single crack. The inspector is looking at the structure. Your documentation is the structure. Where it is thin, the characterization shifts from medicine to something else, and that shift, once the government commits to it, is difficult to reverse.
In three cases we reviewed in the past eighteen months, the practitioners maintained patient records that would have withstood any administrative audit. Their prescribing was aggressive by the standards of their peers but supported by individualized treatment plans, diagnostic imaging, and documented patient histories. Those cases resolved on the administrative track. The documentation did not merely protect the practitioners from criminal referral. It made criminal referral untenable, because the evidence necessary to demonstrate a knowing departure from professional practice did not exist.
The Sentences That Make the News
A physician convicted under 21 U.S.C. § 841 faces statutory penalties that can reach twenty years per count. In practice, sentences in physician prosecution cases have ranged from probation to decades of imprisonment, depending on the volume of substances involved, the presence of patient harm, and the degree to which the court finds the physician functioned as a distributor rather than a clinician.
The Done Global prosecution in the Northern District of California resulted in the conviction of a telehealth company’s founder and clinical president in November 2025 for conspiracy and unlawful distribution of controlled substances. The government alleged the platform facilitated access to over forty million Adderall prescriptions through a subscription model that replaced clinical judgment with volume. Sentencing remains pending. The case matters not because telehealth is suspect, but because the government argued that the business model itself had consumed the medicine, that by the time a prescription reached a patient, the clinical decision behind it had already been made by a revenue target.
The question is never whether you prescribed controlled substances. The question is whether the act of prescribing was, by the time the government examined it, still recognizable as medicine.
A Texas physician received twenty years after operating what prosecutors characterized as a pill mill. His wife received over fifteen years. The practice that generated those sentences had, at some earlier point, been a medical practice. What changed was not necessarily what occurred inside the examination rooms. What changed was how the government was permitted to describe it.
The Number No One Mentions
Most DEA investigations of physician practices do not result in criminal prosecution. The overall risk of DEA criminal action as a percentage of total physicians remains small. A study analyzing the DEA’s own database of criminal prosecutions between 2004 and 2017 found an average of eighteen prosecutions per year nationally.
Eighteen.
But the smallness of that number conceals a secondary truth. When the DEA does pursue criminal charges, the conviction rate is formidable, because by the time a case reaches indictment the government has invested months or years in evidence collection. The case is not filed on suspicion. It is filed on certainty, or something close enough to certainty that the distinction becomes a question for twelve people in a jury box.
This is why the answer to the question is neither yes nor no. It is: the outcome depends on what happens during a window you may not yet know has opened, and on whether the documentation in your files tells a story the government cannot rewrite.
What You Control
The Controlled Substances Act requires practitioners to maintain complete and accurate records of all controlled substances received, administered, and dispensed. This is not a recommendation. It is the regulatory infrastructure upon which your defense, if one becomes necessary, will be constructed.
A compliance audit conducted before the DEA arrives is worth more than the most skilled attorney retained after. We have addressed this in a different context, but the principle does not change: the best defense against a federal investigation is the absence of evidence that could sustain one. Self audits of prescribing patterns, documentation protocols, and inventory controls do not eliminate risk. They reduce the surface area upon which an investigation can find purchase.
There is a particular silence in an examination room at five o’clock on a Friday, when the last patient has gone and the charts are closed. In that silence, the question is not whether the DEA will investigate. It is whether, if it does, the records you kept will speak for you or against you.
Consultation is where that question begins to find its answer.